Your browser doesn't support javascript.
loading
MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity.
Schütze, Kerstin; Groß, Miriam; Cornils, Kerstin; Wustrau, Katharina; Schneppenheim, Sonja; Lenhartz, Henning; Korenke, G Christoph; Janka, Gritta; Ledig, Svea; Müller, Ingo; Ehl, Stephan; Lehmberg, Kai.
Afiliación
  • Schütze K; Division of Pediatric Stem Cell Transplantation and Immunology in the Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.
  • Groß M; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Cornils K; Children's Cancer Research Institute Hamburg, Hamburg, Germany.
  • Wustrau K; Institute for Immunodeficiency, Center for Chronic Immunodeficiency, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schneppenheim S; Faculty of Biology, University of Freiburg, Freiburg, Germany.
  • Lenhartz H; Division of Pediatric Stem Cell Transplantation and Immunology in the Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.
  • Korenke GC; Children's Cancer Research Institute Hamburg, Hamburg, Germany.
  • Janka G; Division of Pediatric Stem Cell Transplantation and Immunology in the Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.
  • Ledig S; Medilys Laborgesellschaft mbH, Hamburg, Germany.
  • Müller I; Catholic Children's Hospital Wilhelmstift, Hamburg, Germany.
  • Ehl S; Department of Neuropediatrics, University Children's Hospital, Klinikum Oldenburg, Oldenburg, Germany.
  • Lehmberg K; Division of Pediatric Stem Cell Transplantation and Immunology in the Department of Pediatric Hematology and Oncology, University Medical Center Eppendorf, Hamburg, Germany.
Blood Adv ; 7(8): 1531-1535, 2023 04 25.
Article en En | MEDLINE | ID: mdl-36206192

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Citotoxicidad Inmunológica / Enfermedades de Inmunodeficiencia Primaria Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Citotoxicidad Inmunológica / Enfermedades de Inmunodeficiencia Primaria Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Alemania